← FDA Drug Approvals (Drugs@FDA)

ENALAPRIL MALEATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ANNORA PHARMA · Approved 2022-02-24

Drug application

FDA Application #

ANDA214467

Application type

Abbreviated New Drug Application (Generic)

Brand name

ENALAPRIL MALEATE

Generic name

ENALAPRIL MALEATE

Active ingredients

ENALAPRIL MALEATE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

ANNORA PHARMA

Manufacturer

NorthStar RxLLC

First approval

2022-02-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown